ArticleFrontiers in pharmacology2025

A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosis.

David J Nikolic-Paterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.